Clinical Interpretation and Cutoff Scores for ABILHAND Questionnaire in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Sponsors: Pamukkale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients
Conditions: Cardiac Rehabilitation; Rheumatoid Arthritis; Hypertension Interventions: Behavioral: Exercise Sponsors: Kayseri City Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Conditions: Sj ögrens Disease; Systemic Lupus Erythematosus; Rheumatoid Arthritis Interventions: Biological: VAY736 1ml PFS; Biological: VAY736 2 ml PFS; Biological: VAY736 2ml AI Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
The effects of intermittent fasting diet on quality of life, clinical symptoms, inflammation, and oxidative stress in overweight and obese postmenopausal women with rheumatoid arthritis: study protocol of a randomized controlled trial
DiscussionStudies show fasting has beneficial effects on inflammatory markers and results in an improvement in the health of different populations. Literature review shows it seems there is no study in this field to evaluate the effects of IF on RA patients, and they are limited to other types of fasting. However, studies show IF can have many positive effects on chronic and autoimmune diseases. Therefore, IF may have positive effects on these patients.Trial registrationIRCT20230217057441N1. Registered on 14 February 2023.https://en.irct.ir/user/trial/68669. (Source: Trials)
Source: Trials - March 5, 2024 Category: Research Source Type: clinical trials
Vasodilator and Exercise Study for DMD (VASO-REx)
Conditions: Duchenne Muscular Dystrophy; Duchenne Disease; Muscular Dystrophy; Muscular Dystrophy in Children; Vasodilation; Exercise; DMD Interventions: Drug: Tadalafil; Drug: Placebo; Other: Exercise Training Sponsors: University of Florida; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Predictive Utility of a Short-term Improvement in Objectively Measured Physical Activity in Rheumatoid Arthritis (PUSIPA)
Conditions: Rheumatoid Arthritis; Fibromyalgia, Secondary; Fatigue; Physical Inactivity Sponsors: Hospital of South West Jutland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Comparison of RA TKA Systems: MAKO vs VELYS
Conditions: Knee Osteoarthritis; Knee Arthritis; Knee Disease Interventions: Device: Stryker Triathlon with MAKO Robotic-Arm; Device: DePuy Attune with VELYS Robotic-Assistance Sponsors: Southeast Orthopedic Specialists; DePuy Orthopaedics; Stryker Orthopaedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis
Conditions: Sarcopenia Sponsors: Kayseri City Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid Interventions: Behavioral: Mindfulness Program Sponsors: University of California, San Francisco; National Center for Complementary and Integrative Health (NCCIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor)
Conditions: Gout Arthritis Interventions: Drug: dose-5 group; Drug: dose-1 group; Drug: dose-2 group; Drug: dose-4 group; Drug: dose-3 group Sponsors: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis Interventions: Drug: Silymarin; Drug: Placebo Sponsors: Phramongkutklao College of Medicine and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Phase 3 Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: LNK01001; Drug: Placebo Sponsors: Lynk Pharmaceuticals Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Treatment of Topical Ketorolac Gel in Acute Gouty Flare
Conditions: Acute Gouty Arthritis; Acute Pain; Gout Flare Interventions: Drug: Ketorolac Tromethamine 15 MG/ML; Drug: Ketorolac Tromethamine Sponsors: Novilla Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
Conditions: Telemedicine; Telehealth; eHealth; Rheumatic Diseases; Arthritis, Rheumatoid; Spondylarthritis Interventions: Device: IMIDOC Sponsors: Instituto de Investigaci ón Hospital Universitario La Paz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
Conditions: Gout Arthritis Interventions: Drug: Recombinant Anti-IL-1 β Humanized Monoclonal Antibody Injection 100 mg; Drug: Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg; Drug: Colchicine 0.5 mg Sponsors: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
